Article info

Download PDFPDF
CP-014 Trabectedin plus pegylated liposomial doxorubicin in relapsed ovarian cancer: outcomes in award-treated patients and Platinum Free Interval

Authors

Citation

Bellavia G, Scorsone C, Cascone V, et al
CP-014 Trabectedin plus pegylated liposomial doxorubicin in relapsed ovarian cancer: outcomes in award-treated patients and Platinum Free Interval

Publication history

  • First published February 24, 2014.
Online issue publication 
September 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.